Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients

M A Karsdal1, K M Verburg2, C R West2

  • 1Nordic Bioscience, Herlev Hovedgade, DK-2730 Herlev, Denmark.

Insights

Biomarkers can predict rapidly progressive osteoarthritis (RPOA) in osteoarthritis (OA) patients treated with tanezumab. This study identified specific biomarker combinations to identify patients at risk of RPOA type-2.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Pharmacology

Background:

  • Osteoarthritis (OA) requires effective and safe pain management.
  • Tanezumab, a nerve growth factor (NGF) antibody, shows high efficacy but carries a risk of rapidly progressive osteoarthritis (RPOA) when combined with chronic NSAID use.
  • Identifying OA patients at risk for RPOA is crucial for safe treatment.

Purpose of the Study:

  • To identify biochemical biomarkers predicting RPOA type-2 in OA patients.
  • To phenotype OA patients at risk for RPOA type-2, considering both limited and chronic NSAID users.
  • To develop predictive models for RPOA type-2 risk.

Main Methods:

  • Analyzed biomarker data from OA patients in tanezumab trials, categorized by NSAID usage (limited <90 days, chronic ≥90 days).
  • Utilized 47 RPOA type-2 cases and 92 controls.
  • Developed non-linear and linear multivariable predictive models.

Main Results:

  • In limited NSAID users, two baseline biomarkers predicted RPOA type-2 with 71% ROC AUC, showing an 8-fold increased relative risk.
  • In chronic NSAID users, five biomarkers predicted RPOA type-2 with 78% AUC, indicating a 4-fold increased relative risk.
  • Identified specific biomarker combinations associated with RPOA type-2 development.

Conclusions:

  • Biomarker combinations can identify OA patients at risk for RPOA type-2.
  • These findings may elucidate the underlying pathology of RPOA type-2.
  • This exploratory study provides a basis for future research into RPOA prevention and management.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
857
Taping Over Different Ground Profiles01:12

Taping Over Different Ground Profiles

Taping over varying ground profiles requires careful adaptation to achieve accurate measurements. On smooth, level ground with minimal vegetation, the tape can rest directly on the ground. Here, the taping team, typically consisting of a head and a rear tapeman, coordinates their positions with clear communication. The rear tapeman holds the tape at the starting point and guides the head tapeman toward a range pole placed beyond the endpoint, using hand or voice signals to ensure alignment.On...
378
Rapidly Varying Flow01:24

Rapidly Varying Flow

Rapidly varying flow (RVF) in open channels is characterized by abrupt changes in flow depth over a short distance, with the rate of depth change relative to distance often approaching unity. These flows are inherently complex due to their transient and multi-dimensional nature, making exact analysis difficult. However, approximate solutions using simplified models provide valuable insights into their behavior.Key Features of Rapidly Varying FlowRVF is commonly observed in scenarios involving...
495